Cyltezo is a medication that falls under the category of biologic drugs known as tumor necrosis factor (TNF) inhibitors. It is used to treat various autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and Crohn’s disease. Cyltezo works by targeting and blocking TNF, a protein in the body that plays a key role in inflammation.

Patients who are prescribed Cyltezo can expect to see a reduction in symptoms such as joint pain, stiffness, and swelling. This can lead to improved mobility and overall quality of life. It is important to note that Cyltezo is not a cure for these conditions, but rather a way to manage symptoms and slow down disease progression.

As with any medication, there are potential side effects associated with Cyltezo. These can include injection site reactions, infections, and an increased risk of certain types of cancer. It is important for patients to discuss these risks with their healthcare provider before starting treatment.

It is also crucial for patients to follow their healthcare provider’s instructions carefully when taking Cyltezo. This may include regular monitoring of blood tests and other health parameters to ensure the medication is working effectively and not causing any harm.

Overall, Cyltezo can be a valuable treatment option for patients with autoimmune conditions who have not responded well to other medications. By working with their healthcare provider and closely monitoring their health, patients can experience relief from symptoms and improve their overall well-being.